Both in Pharmaceuticals
Sagimet Biosciences Inc. Series A vs Aquestive Therapeutics
Over the past year SGMT returned +34.8% and AQST returned −17.3%; their daily moves had a correlation of 0.11.
SGMT +34.8% AQST −17.3%Growth of $1, one year, split-adjusted
| Metric | SGMT | AQST |
|---|---|---|
| Price | $9.33 | $4.67 |
| Market cap | $579.9M | $586.1M |
| Today | −6.14% | −1.68% |
| 1 month | −11.6% | −7.0% |
| 6 months | +105.1% | +15.6% |
| Year to date | +57.6% | −27.7% |
| 1 year | +27.1% | −22.0% |
| Revenue growth (YoY) | — | +38.1% |
| Gross margin | — | 70.9% |
| Net margin | — | −165.5% |
| P/E (TTM) | — | — |
| Price / sales | — | 10.8× |
| Net cash | $240.1M | $47.8M |
| Dividend yield | — | — |
| Volatility (60d) | 69.4% | 48.4% |
| Short % of float | 36.3% | 25.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).